{"slideshow_credits": null, "snippet": "Patients with idiopathic pulmonary fibrosis who were given pirfenidone or nintedanib declined more slowly, researchers in two studies reported.", "abstract": "Researchers find drugs that, for first time, can slow decline of people with fatal lung disease, idiopathic pulmonary fibrosis; studies of two experimental drugs, one made by InterMune, another by Boehringer Ingelheim, were published in The New England Journal of Medicine and presented San Diego at meeting of American Thoracic Society.", "section_name": "Health", "print_page": "12", "document_type": "article", "byline": {"person": [{"firstname": "Denise", "role": "reported", "lastname": "GRADY", "rank": 1, "organization": ""}], "original": "By DENISE GRADY", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/05/19/health/drugs-found-to-aid-breathing-in-a-fatal-lung-disease.html", "lead_paragraph": "Patients with idiopathic pulmonary fibrosis who were given pirfenidone or nintedanib declined more slowly, researchers in two studies reported.", "headline": {"main": "Drugs Found to Aid Breathing in a Fatal Lung Disease", "print_headline": "In a Disease That\u2019s Fatal, 2 Drugs Help Lungs Cope"}, "_id": "537925c238f0d805525a3384", "word_count": "711", "multimedia": [], "pub_date": "2014-05-19T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"value": "Boehringer Ingelheim GmbH", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Idiopathic Pulmonary Fibrosis", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "InterMune Inc", "name": "organizations", "is_major": "Y", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "News"}